Finance

Lists
NUVB:NYSE
Nuvation Bio Inc
4,75 US$
+1,50%
(+0,070) 1D
4,70 US$
-1,05% (-0,050)
After hours
Closed: 15 ოქტ, 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUVB...
Open
4,74 US$
High
4,86 US$
Low
4,67 US$
Mkt. cap
1,67 მლრდ.
Avg. vol.
5,41 მლნ.
Volume
4,82 მლნ.
52-wk high
9,75 US$
52-wk low
3,36 US$
EPS
-0,44 US$
Beta
1,61
Shares outstanding
351,12 მლნ.
No. of employees
305
Open
4,74 US$
High
4,86 US$
Low
4,67 US$
Mkt. cap
1,67 მლრდ.
Avg. vol.
5,41 მლნ.
Volume
4,82 მლნ.
52-wk high
9,75 US$
52-wk low
3,36 US$
EPS
-0,44 US$
Beta
1,61
Shares outstanding
351,12 მლნ.
No. of employees
305
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
11 საათის წინ
Top 3 Penny Stocks To Watch In October 2026
About Nuvation Bio Inc
CEOდავიდ ჰუნგ
Employees305
Founded2018
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 9 analysts giving stock ratings to NUVB in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NUVB in the last 3 months.
Highest
Current 4,75 US$
21,00 US$ (+342,11%)
Average
14,57 US$ (+206,74%)
Lowest
11,00 US$ (+131,58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Buy
Maintained
20,00 US$
+321,1%
10/12/2026
Geoff Meacham
Citi
Buy
Initiated
12,00 US$
+152,6%
10/01/2026
Priyanka Grover
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
David Nierengarten
Wedbush
Buy
Maintained
11,00 US$
+131,6%
09/15/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
09/15/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
12,00 US$
+152,6%
08/21/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
14,00 US$
+194,7%
08/07/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
21,00 US$
+342,1%
08/07/2026
Boris Peaker
JonesTrading
Buy
Reiterated
12,00 US$
+152,6%
08/06/2026
Yaron Werber
TD Cowen
Buy
Reiterated
-
-
06/01/2026
Soumit Roy
JonesTrading
Buy
Maintained
12,00 US$
+152,6%
04/06/2026
Michael Yee
UBS
Hold
Maintained
7,00 US$
+47,4%
03/03/2026
Last report
6 აგვ. 2026
Fiscal period
Q2 2026
-0,15 US$ / -0,12 US$
-25,15%miss
Revenue / Est. (USD)
31,69 მლნ. / 28,70 მლნ.
+10,42%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
13,12 მლნ.
41,86 მლნ.
83,23 მლნ.
31,69 მლნ.
Cost of goods sold
3,35 მლნ.
1,28 მლნ.
5,99 მლნ.
9,47 მლნ.
Cost of revenue
3,35 მლნ.
1,28 მლნ.
5,99 მლნ.
9,47 მლნ.
Research and development expenses
28,85 მლნ.
34,30 მლნ.
35,05 მლნ.
30,66 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,36 მლნ.
40,33 მლნ.
38,31 მლნ.
42,59 მლნ.
Operating expense
66,20 მლნ.
74,62 მლნ.
73,36 მლნ.
73,25 მლნ.
Total operating expenses
69,55 მლნ.
75,90 მლნ.
79,35 მლნ.
82,72 მლნ.
Operating income
-56,43 მლნ.
-34,04 მლნ.
3,88 მლნ.
-51,04 მლნ.
Other non operating income
1,14 მლნ.
-1,18 მლნ.
3,11 მლნ.
-179,00 ათ.
EBT including unusual items
-55,79 მლნ.
-36,59 მლნ.
5,40 მლნ.
-62,84 მლნ.
EBT excluding unusual items
-55,80 მლნ.
-36,59 მლნ.
5,39 მლნ.
-53,38 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-55,79 მლნ.
-36,59 მლნ.
5,40 მლნ.
-62,84 მლნ.
Net profit margin
-425,24%
-87,40%
6,48%
-198,31%
Earnings per share
-0,14
-0,09
0,04
-0,15
Interest and investment income
6,03 მლნ.
5,30 მლნ.
5,11 მლნ.
4,60 მლნ.
Interest expense
-6,53 მლნ.
-6,67 მლნ.
-6,71 მლნ.
-6,76 მლნ.
Net interest expenses
-501,00 ათ.
-1,38 მლნ.
-1,60 მლნ.
-2,16 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-55,90 მლნ.
-33,50 მლნ.
4,42 მლნ.
-50,50 მლნ.
Gain or loss from assets sale
-4,00 ათ.
3,00 ათ.
-
-1,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები